Pulse Biosciences

Pulse Biosciences delivers cutting‑edge nanosecond pulsed‑field ablation tech via its CellFX platform—targeting skin lesions and cardiac arrhythmias—and positions itself as a pioneering medical‑equipment manufacturer in the U.S.

Headquarters: United States (USA)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Manufacturing
Industry: Medical Equipment Manufacturing

Employees: 75
HQ: Miami

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
PLSE	Pulse Biosciences Cap: 1.0B	EQUITY	NCM	USD	US74587B1017	Active	📈